Predicting of Mechanical Ventilation and Outcomes by Using Models and Biomarker in Guillain-Barré Syndrome

• Published in: Neurology and therapy Vol. 12; no. 6; pp. 2121 - 2132
• Main Authors: Yao, Jiajia, Zhou, Rumeng, Liu, Yue, Liu, Yin, Cao, Qian, Lu, Zuneng
• Format: Journal Article
• Language: English
• Published: Cheshire Springer Healthcare 01.12.2023; Adis, Springer Healthcare
• Subjects: Erasmus GBS Respiratory Insufficiency Score; Guillain-Barré syndrome (GBS); Internal Medicine; Medicine; Medicine & Public Health; Modified Erasmus GBS outcome score; Neurology; Original Research; Prognosis; Serum albumin; Modified Erasmus GBS outcome score; Serum albumin; Erasmus GBS Respiratory Insufficiency Score; Prognosis; Guillain-Barré syndrome (GBS)
• ISSN: 2193-8253; 2193-6536
• DOI: 10.1007/s40120-023-00546-w

Background Guillain-Barré syndrome (GBS) is an acute inflammatory neuropathy. The Erasmus GBS Respiratory Insufficiency Score (EGRIS) and the modified Erasmus GBS Outcome Score (mEGOS) are prognostic models used in the prediction of mechanical ventilation and outcome. Thus far, there are only few biomarkers for the prognosis prediction of GBS patients, and albumin level is one that is promising. Methods Patients diagnosed with GBS from 2013 to 2022 at Renmin Hospital, Wuhan University, China, were included. Patients hospitalized between 2016 and 2022 underwent short- and long-term follow-ups. The correlations between EGRIS/mEGOS and mechanical ventilation and outcome were evaluated. Serum albumin level was examined the day after admission. Furthermore, we also investigated whether the level of serum albumin was useful in predicting disease severity or poor outcome. Results In all, 145 patients were enrolled. Nineteen patients (13.1%) who required mechanical ventilation had higher Hughes GBS disability score (HGDS) at admission and discharge ( P  < 0.05 and P  < 0.0001, respectively), shorter time from onset to admission and treatment ( P  < 0.01 and P  < 0.001, respectively) and longer hospital stays ( P  < 0.001) than patients who did not require mechanical ventilation. High EGRIS scores were linked with the need for mechanical ventilation ( r  = 0.427, P  < 0.001, AUC = 0.623). Seventy-one patients were admitted between 2016 and 2022. Of these, 65 patients had a 4-week follow-up and 61 had a 6-month follow-up. Higher mEGOS scores at admission and 7 days after admission significantly correlated with short- ( P  < 0.0001 and P  < 0.0001) and long-term ( P  < 0.05 and P  < 0.05) outcomes, respectively. No significant difference in outcome was found between different subtypes (4 weeks [ P  = 0.099] and 6 months [ P  = 0.172]). Patients with lower albumin level tended to have higher HGDS (at admission P  < 0.05, at nadir P  < 0.001, and at discharge P  < 0.001) and higher properties of the need of mechanical ventilation ( P  < 0.05) and ICU stay ( P  < 0.05) than those with normal albumin levels. Those with low albumin levels were also unable to walk independently at 6 months ( P  < 0.01). Conclusions mEGOS scores predicted the outcomes of GBS patients in China, and EGRIS score predicted the need for mechanical ventilation in these patients. Albumin level at admission correlated well with disease severity and outcomes.